[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 1,166
Citations 0
Comment & Response
February 3, 2020

Alzheimer Disease, Biomarkers, and Clinical Symptoms—Quo Vadis?

Author Affiliations
  • 1Gait and Brain Lab, Parkwood Institute, Lawson Health Research Institute, School of Medicine and Dentistry, Division of Geriatric Medicine, Departments of Medicine and Epidemiology and Biostatistics, University of Western Ontario, London, Ontario, Canada
  • 2University of Calgary, Calgary, Alberta, Canada
  • 3University of Alberta, Edmonton, Alberta, Canada
JAMA Neurol. Published online February 3, 2020. doi:10.1001/jamaneurol.2019.4959

To the Editor We read with interest the article from Jack et al,1 and its Editorial that shows that the prevalence of 2 neuropathologic hallmarks of Alzheimer disease (AD), β-amyloid plaques, and neurofibrillary tangles is much higher than the prevalence of 3 associated clinical manifestations: mild cognitive impairment, dementia, and probable AD.1 Notably, this asymptomatic prevalence of brain load biomarker increased by 3 times in those 85 years and older.1

Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words